From Jen: Cardio Flashcards

(49 cards)

1
Q

Hydrochlorothiazide

A

Diuretic

Adverse:
↓K+
Mild ↑ lipids
↑ uric acid
lassitude (lethargy)
↑ Ca2+
hyperglycemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Loop diuretics

A

Diuretic

Adverse: 
K+ wasting
hypotension
ototoxicity
metabolic alkalosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Clonidine

A

α2 agonist

Adverse:
dry mouth
sedation
severe rebound HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Methyldopa

A

Adverse: sedation

Positive Coombs test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

reserpine

A

Depletes central and peripheral catecholamines (inhibits VMAT-packaging catecholamines into vesicles)

Adverse:
sedation
depression
nasal stuffiness
diarrhea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Guanethidine

A

Reduces catecholamine release

Adverse: orthostatic and exercise hypotension
sexual dysfunction
diarrhea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Prazosin

A

α1 antagonist

Adverse:
orthostatic hypotension (1st dose)
dizziness
headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

beta blockers

A
Adverse:
impotence
asthma exacerbation
bradycardia
CHF
AV block
CNS effects: sedation, sleep alterations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hydralazine

A

Vasodilator

Adverse:
nausea
headache
lupus-like syndrome
reflex tachycardia (prevent with beta blocker)
angina
salt retention (prevent with diuretic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Minoxidil

A

Vasodilator

Adverse: hypertrichosis
reflex tachycardia (prevent with beta blocker)
angina
salt retention (prevent with diuretic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nifedipine

Verapamil

A

Calcium channel blocker
vasodilator

Adverse:
flushing
constipation (verapamil)
AV block (verapamil)
nausea
edema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Nitroprusside

A

vasodilator

cyanide toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diazoxide

A

vasodilator

Adverse: hyperglycemia (reduces insulin release, hypotension)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ACE inhibitors

A

Captopril, enlapril, fosinopril

Adverse: cough
hyperkalemia
angioedema
taste changes
hypotension
fetal renal damage in pregnancy
rash increase renin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Angiotenin II receptor inhibitors

ARB

A

Losartan

Adverse: fetal renal toxicity, hyperkalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Hydralazine

MOA

A

MOA: increase cGMP; smooth muscle relaxation (arterioles > veins)

***afterload reduction

Use: severe HTN, CHF
First line in pregnancy with methyldopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Hydralazine

Toxicity

A
compensatory tachycardia (contraindicated in angina, CAD)
fluid retention
nausea
headache
angina
lupus-like syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Minoxidil

A

K+ channel opener- hyperpolarized and relaxes vascular smooth muscle

Use: Severe HTN

toxicity: hypertrichosis
pericardial effusion
reflex tachycardia
angina
salt retention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Nifedipine
Diltiazem
Verapamil

A

Calcium channel blockers
-block voltage dependent L-type calcium channels of cardiac and smooth muscle; reduce muscle contractility

Use: HTN, angina, arrhythmias (not nifedipine), prinzmetal’s angina, Raynaud’s

Toxicity:
cardiac depression
peripheral edema
flushing
dizziness
constipation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Isosorbide dinitrate

nitroglycerin

A

Vasodilate by releasing NO in smooth muscle, causing increased cGMP and smooth muscle relaxation

Dilates veins» arteries
**decrease preload

Use: angina, pulmonary edema, erection enhancer

Toxicity: tachycardia, hypotension, flushing, headache
“Monday disease” in industrial exposure: loss of tolerance for vasodilating action during weekend result in in tachycardia, dizziness and headache on reexposure.

21
Q

Malignant HTN treatment

A

Nitroprusside- short acting, increase cGMP via direct release of NO

Fenoldopam- D1 receptor agonist: relaxes renal vascular smooth muscle

Diazoxide- K+ channel opener: hyperpolarizes and relaxes vascular smooth muscle

22
Q

Anti-anginal therapy

GOAL

A

Reduce myocardial O2 consumption by decreasing one or more of:

  • end diastolic volume
  • BP
  • HR
  • contractility
  • ejection time
23
Q

Nitrate use in angina:

EDV
BP
Contractility
HR
Ejection time
O2 consumption
A

*Decrease Preload

EDV: ↓
BP: ↓
Contractility: ↑ (reflex)
HR: ↑ (reflex)
Ejection Time: ↓
O2: ↓
24
Q

Beta blocker use in angina:

EDV
BP
Contractility
HR
Ejection time
O2 consumption
A
EDV ↑
BP ↓
Contractility ↓
HR ↓
Ejection Time ↑ (slower)
O2: ↓
25
Nitrates + beta blocker in angina ``` EDV BP Contractility HR Ejection time O2 consumption ```
``` EDV: no change BP: ↓ Contractility: No change HR: ↓ Ejection Time: No change O2: ↓↓ ```
26
HMG CoA reductase inhibitors
Statins MOA: inhibit cholesterol precursor, mevalonate ↓↓↓ LDL ↑HDL ↓Triglycerides Adverse: reversible increase in LFTs, rhabdomyolysis
27
Niacin
MOA: inhibits lipolysis in adipose tissue; reduces hepatic VLDL secretion ↓↓ LDL ↑↑ HDL ↓Triglycerides Adverse: flushing, decrease in by long term use or ASA
28
Bile acid resin
Cholestyramine, colestipol, colesevelam MOA: prevent reabsorption of bile acids ↓↓ LDL Slightly ↑ HDL Slightly ↑ Triglycerides Adverse: GI side effects, fat soluble vitamin deficiency
29
Ezetimibe
Competitively inhibit cholesterol absorption at brush border ↓↓ LDL no effect on HDL or triglycerides Adverse: Rare ↑ LFTs
30
Fibrates
Gemfibrozil, clofibrate, bezafibrate, fenofibrate MOA: upregulate lipoprotein lipase, increasing TG clearance ↓ LDL ↑ HDL ↓↓↓ Triglycerides Adverse: myositis, increased LFTs
31
Cardiac glycosides
Digoxin: 75% bioavailability 20-40% protein bound half life: 40hrs urinary excretion
32
Digoxin
MOA: direct inhibition of Na/K ATPase leads to inhibition of Na/Ca exchanger; increased intracellular Ca with positive inotropy. Also stimulates vagus nerve ``` Use: CHF (↑ contractility) atrial fibrillation (↓ conduction at AV node and depression of SA node) ```
33
Digoxin Toxicity
↑ PR, ↓QT, scooping of ST segment, T wave inversion ↑ parasympathetic activity (SLUDGE) arrhythmia toxicity made worse by : renal failure (impaired excretion), hypokalemia (competitively binds K binding site on Na/K ATPase), quinidine (decrease clearance, displaces dig from tissue binding sites) Antidote: Normalize K+ lidocaine, cardiac pacer, anti-digitoxin Fab fragments, Mg2+
34
Class I antiarrhythmics
Na+ channel blockers local anesthetics, slow or block conduction (slow upstroke) Decrease slop of phase 4 depolarization in pacemaker cells (↑ threshold for firing) State dependent-selectively depress tissue that is frequently depolarized
35
Class IA Drugs/MOA
Quinidine, Procainamide, Disopyramide MOA: ↑ AP duration, ↑ effective refractory period, ↑ QT interval Use: Affect atrial and ventricular arrhythmias **esp. rentrant and ectopic SVT, Vtach, WPW
36
Class IA Toxicity
Thrombocytopenia, Torsades de pointes (↑ QT interval) Quinidine: cinchonism (headache/tinnitus) Desopyramide: heart failure Procainamide: reversible SLE-like syndrome
37
Class IB Drugs/MOA
Lidocaine, Mexiletine, Tocainide MOA: ↓ AP duration, affect ischemic or depolarized Purkinje and ventricular tissue Useful in acute ventricular arrhythmias **esp. post-MI or digitalis-induced arrhythmias **Class IB is BEST for post-MI**
38
Class IB Toxicity
Lidocaine, Mexiletine, Tocainide local anesthetic, CNS stimulation/depression, CV depression
39
Class IC Drugs/MOA
Flecainide, encainide, propafenone MOA: prolongs refractory period in AV node, no effect on AP duration Use: SVTs, afib, last resort in refractory VTach
40
Class IC Toxicity
Flecainide, encainide, propafenone Pro-arrhythmic, especially post-MI (Class IC = Contraindicated) Significantly prolongs the refractory period in AV node
41
Class II (beta blockers) Drugs/MOA
Propranolol, esmolol, metoprolol, atenolol, timolol, carvedilol MOA: Block beta receptor: ↓ cAMP and Ca2+ currents (↓ slope of phase 4) Suppress abnormal pacemakers by ↓ slope of phase 4 (AV node particularly sensitive)- ↑ PR interval Uses: Vtach, SVT, to slow ventricular rate during atrial flutter/fibrillation
42
Class II (beta blockers) Toxicity
``` Impotence asthma exacerbation CHF bradycardia AV block sedation/sleep alterations mask hypoglycemia metoprolol: dyslipidemia ```
43
``` Class III (K+ channel blockers) ``` Drugs/MOA
Sotalol, ibutilide, amiodarone MOA: ↑ AP duration, ↑ refractory period, ↑ QT interval Use: when other antiarrhythmic fail
44
``` Class III (K+ channel blockers) ``` Toxicity
Sotalol- torsades de pointes, excessive beta block ibutilide- torsades amiodarone- pulmonary fibrosis, hepatotoxicity, corneal deposits, skin deposits, neurologic effects, constipation, CV effects (bradycardia, CHF, heart block), hypo/hyperthyroidism
45
``` Class IV (Calcium channel blockers) ``` Drugs/MOA
verapamil, diltiazem MOA: primarily affect AV nodal cells, ↓ conduction velocity, ↑ refractory period and PR interval Use: prevention of nodal arrhythmias
46
``` Class IV (Calcium channel blockers) ``` Toxicity
Verapamil, diltiazem Constipation, flushing, edema, CV effects (CHF, AV block, sinus node depression)
47
Adenosine
↑ K+ out of cells, hyperpolarizing the cell and decreasing intracellular Ca **very short acting** Use: drug of choice when abolishing AV nodal arrhythmias Toxicity: flushing, hypotension, chest pain
48
K+
Depresses ectopic pacemakers in hypokalemia (digoxin toxicity)
49
Mg2+
Effective in torsades de pointes and digoxin toxicity